Citations

Clear

62 citation(s) found for "Robinson, Steven".

An Insidious Cardiac Sarcoma Presenting with Progressive Neurologic Dysfunction
Pasalic, Dario , Hegerova, Livia , Hegerova, Livia T, Robinson, Steven, Gonsalves, Wilson I. , Robinson, Steven I.

Mayo Clinic

Rare Tumors | October 18, 2013 | Volume: 5 | Issue: 4 | Pages: 183-184

10.4081/rt.2013.e56 | PMID 24416490 Get It

Central nervous system metastases as the presentation of primary cardiac sarcoma are a very rare entity, with only a few previously reported cases. Sarcomas specifically make up 10 to 20% of all primary cardiac tumors. Patients with primary cardiac tumors typically present with cardiac symptomatology that may include arrhythmias, obstruction to blood flow and valve function, or symptoms of heart failure. We report a unique case of a patient with a primary cardiac sarcoma who presented with progressive neurologic dysfunction secondary to brain metastases without any preceding cardiac symptoms. We describe our novel management of these unique cases and discuss the current medical and surgical approaches to treating neurologic metastases from cardiac sarcoma.
Adult Ewing Sarcoma: Survival and Local Control Outcomes in 102 Patients with Localized Disease
Robinson, Steven I. , Okuno, Scott H. , Rose, Peter S. , Ahmed, Safia K. , Laack, Nadia N. , Robinson, Steven I

Mayo Clinic

Sarcoma | June 11, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-7

10.1155/2013/681425 | PMID 23840168 Get It

Objectives. To assess the clinical features and local control (LC) outcomes in adult patients with localized Ewing Sarcoma (ES).Methods. The records of 102 ES patients with localized disease ≥18 years of age seen from 1977 to 2007 were reviewed. Factors relevant to prognosis, survival, and LC were analyzed.Results.The 5-year overall survival (OS) and event-free survival (EFS) were 60% and 52%, respectively, for the entire cohort. Treatment era (1977–1992 versus 1993–2007) remained an independent prognostic factor for OS on multivariate analysis, with improved outcomes observed in the 1993–2007 era (P=0.02). The 5-year OS and EFS for the 1993–2007 era were 73% and 60%, respectively. Ifosfamide and etoposide based chemotherapy and surgery were more routinely used in the 1993–2007 era (P<0.01). The 5-year local failure rate (LFR) was 14%, with a 5-year LFR of 18% for surgery, 33% for radiation, and 0% for combined surgery and radiation in the 1993–2007 era (P=0.17).Conclusion. Modern survival outcomes for adults with localized ES are similar to multi-institutional results in children. This improvement over time is associated with treatment intensification with chemotherapy and increased use of surgery. Aggressive LC (combined surgery and radiation) may improve outcomes in poor prognosis patients.